Clinical Trials on Advanced Malignant Solid Neoplasm
Total 11536 results
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Malignant TumorsChina
-
SUNHO（China）BioPharmaceutical CO., Ltd.RecruitingAdvanced Malignant TumorsChina
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Malignant TumorsChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.Not yet recruitingAdvanced Malignant TumorChina
-
Dragonboat Biopharmaceutical Company LimitedWest China HospitalRecruitingAdvanced Malignant TumorChina
-
Atridia Pty Ltd.CompletedAdvanced Malignant TumorsAustralia
-
Qilu Pharmaceutical Co., Ltd.Active, not recruiting
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Enrolling by invitationAdvanced Malignant TumorsChina
-
University of California, San FranciscoSwim Across AmericaRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Childhood CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid NeoplasmUnited States
-
4SC AGCompletedMalignant Lymphomas | Advanced and Incurable Solid TumorsGermany
-
Shanghai Yuyao Biotech Co., Ltd.RecruitingAdvanced Solid Tumor | Hematological MalignancyChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Not yet recruitingMetastatic Malignant Solid NeoplasmUnited States
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Esperance Pharmaceuticals IncCompletedAdvanced Solid Tumors | Solid TumorsUnited States
-
GenmabBioNTech SERecruitingMalignant Solid TumorJapan
-
Peking University Cancer Hospital & InstituteRecruiting
-
GeneScience Pharmaceuticals Co., Ltd.RecruitingMalignant Solid TumorsChina
-
Chinese PLA General HospitalRecruiting
-
Shanghai East HospitalRecruitingMalignant Solid TumorChina
-
BayerActive, not recruitingSolid Malignant TumorsFrance, Japan, Taiwan, Korea, Republic of, Spain
-
The First Affiliated Hospital of Guangzhou Medical...Sinotau Pharmaceutical GroupCompletedMalignant Solid TumorsChina
-
SanofiTerminatedMalignant Solid TumorFrance, Spain, Australia, Belgium, Italy, United Kingdom, Taiwan, Estonia, Netherlands, Korea, Republic of, United States, Canada, Germany
-
Eli Lilly and CompanyCompletedMalignant Solid TumorUnited States
-
ImmunityBio, Inc.CompletedMalignant Solid TumourUnited States
-
amcure GmbHCompletedMalignant Solid TumorBelgium, Spain
-
Ono Pharmaceutical Co. LtdCompletedMalignant Solid TumorJapan
-
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.Shenzhen Second People's HospitalUnknown
-
Sagimet Biosciences Inc.CompletedSolid Malignant TumorUnited Kingdom, United States
-
Tianjin Medical University Cancer Institute and...UnknownMalignant Solid TumorsChina
-
SCRI Development Innovations, LLCNovartisCompletedMalignant Solid TumourUnited States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
CAS Lamvac Biotech Co., Ltd.Recruiting
-
University of California, San FranciscoWithdrawnMetastatic Malignant Neoplasm | Locally Advanced Malignant Neoplasm
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Hereditary Malignant NeoplasmUnited States
-
Peking UniversityRecruitingAdvanced Malignant Solid Tumor of Digestive SystemChina
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | WHO Grade 3 Glioma | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Glioma | Recurrent Cholangiocarcinoma | WHO Grade 2 GliomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnPain | Advanced Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)RecruitingAdvanced Malignant NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingOligometastatic Malignant Solid NeoplasmUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Cancer | SurvivorshipUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institute of Nursing Research (NINR) and other collaboratorsActive, not recruitingDelirium | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
Constellation PharmaceuticalsNot yet recruitingSolid Tumor | Hematologic Malignancy | Advanced Malignancies